Evonik Venture Capital invests in Laxxon
3D printed tablets with better drug delivery
09-Mar-2022 -
Evonik Venture Capital has invested in Laxxon Medical. The Nevada, U.S.-based company has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time. Multiple ingredients can also be ...
3D screen printing
drug release
investments
+2